“Breathprints” Could Diagnose Disease

Researchers can identify individuals by the unique chemical signatures in their breath, suggesting that exhalations could be used for metabolomic tests.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

XUE LI / ETH ZURICHEvery individual has a signature composition of metabolites—or compounds produced by chemical reactions in the body—in their exhaled breath, according to a study published this week (April 3) in PLOS ONE. These unique “breathprints” could one day be used in addition to blood or urine tests to reveal biomarkers of disease or test athletes for doping.

Previous work indicated that the presence of infections or even cancer might be detected in breath, but it was not clear whether the metabolic contents of breath varied enough between individuals, and whether each individual’s breathprint remained stable enough over time, to make it a genuine candidate for diagnostic use. To find out, a group of researchers led by Renato Zerobi of the Swiss Federal Institute of Technology in Zurich got 11 volunteers to blow into a mass spectrometer, which almost instantly parsed the exhalation into its chemical components.

Although each person’s breathprint changed slightly from sample to sample over the course of nine days of testing, the researchers observed that every volunteer had a chemical signature that was stable and specific enough to identify ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies